CA
Arrivals (12 mo)
0
0 active ports
Active Ports
0
Distinct US ports with vessel activity
Compliance
Clear
6 lists screened
Data compiled from CBP Licensed Brokers, OpenSanctions, OFAC SDN, BIS Consolidated Screening List · As of 2026-04-28 · Updates daily
Search of the OFAC SDN list for “JENNIFER T. POLO” returned no matches.
Search of the BIS CSL for “JENNIFER T. POLO” returned no matches. This covers the BIS Entity List, Denied Persons List, OFAC SDN, ITAR Debarred, and 10 other U.S. export control lists.
LYNPARZA NEARLY DOUBLED THE TIME PATIENTS LIVED WITHOUT DISEASE PROGRESSION FROM GERMLINE BRCA-MUTATED METASTATIC PANCREATIC CANCER
View on SEC.gov →LYNPARZA GRANTED ORPHAN DRUG DESIGNATION IN JAPAN FOR BRCA-MUTATED METASTATIC PANCREATIC CANCER
View on SEC.gov →LYNPARZAAPPROVED IN THE US AS A 1ST-LINE MAINTENANCE TREATMENT OF GERMLINE BRCA-MUTATED METASTATIC PANCREATIC CANCER
View on SEC.gov →LYNPARZA APPROVED IN EU FOR THE TREATMENT OF GERMLINE BRCA-MUTATED HER2-NEGATIVE ADVANCED BREAST CANCER
View on SEC.gov →AMENDMENT TO LEASE AGREEMENT DATED SEPTEMBER 1, 2019 BETWEEN COSECHEMOS YA S.A.S. AND C.I GRAMULAZ S.C.A.
View on SEC.gov →MORGAN DEMPSEY SMALL/MICRO CAP VALUE FUND SEMIANNUAL REPORT 2-28-17
View on SEC.gov →Source: SEC EDGAR Full-Text Search
Data Sources
No sanctions match
No exact name match found in OpenSanctions global database. This is not a guarantee of compliance — always verify through official channels.
Source: OpenSanctions (OFAC SDN, EU, UN, and 40+ additional lists)
Search the Consolidated Screening List (BIS, OFAC, DDTC) and global sanctions lists.
Search Screening List